Milestone Pharmaceuticals Inc (MIST) - News Archive

Navigating Challenges: Milestone Pharmaceuticals Confronts Financial Struggles Amid FDA Decision for EtripamilMilestone Pharmaceuticals Inc. is currently at a critical junction, as it grapples with significant financial...

Investigation: A Path Forward for Milestone Pharmaceuticals Amid Financial StrugglesMilestone Pharmaceuticals Inc. has recently extended an invitation to investors to discuss its corporate outlook for 2025, coinciding w...

Stepping Up the Game: Milestone Pharmaceuticals Strategic Equity Inducement GrantsMilestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company with a keen focus on developing life-changing treatments, rece...

Milestone Pharmaceuticals Inc. (NASDAQ: MIST), a biopharmaceutical company dedicated to developing innovative cardiovascular medicines, has announced promising news regarding its licensing partner, Ji Xing Pharmaceutica...

FDA Accepts Milestone Pharmaceuticals’ New Drug Application for CARDAMYST Nasal Spray for PSVT Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYSTMONTREAL and CHARLOTTE, N.C., May 29...

Montreal, Canada October 15, 2023 Milestone Pharmaceuticals, a biopharmaceutical company dedicated to the development and commercialization of innovative cardiovascular therapies, is excited to announce a new partnershi...

In an exciting breakthrough for patients suffering from Paroxysmal Supraventricular Tachycardia (PSVT), Milestone Pharmaceuticals unveiled the results of their Etripamil data at The American College of Cardiology Annual...

Paroxysmal supraventricular tachycardia (PSVT) is a common cardiac arrhythmia that affects a significant number of individuals worldwide. Milestone Pharmaceuticals Inc. has recently resubmitted a New Drug Application (N...

Milestone Pharmaceuticals Announces Pricing of Public Offering to Advance Innovative Cardiovascular MedicinesMONTREAL and CHARLOTTE, N.C., Feb. 29, 2024 - Milestone Pharmaceuticals Inc. (Milestone) (Nasdaq: MIST), a bio...

Milestone Pharmaceuticals Inc. Commences Public Offering of Common Shares and Pre-Funded WarrantsMilestone Pharmaceuticals Inc. has recently announced the commencement of an underwritten public offering, featuring the s...

Milestone Pharmaceuticals Inc, a prominent player in the insert industry, has recently found itself under investigation for potential securities law violations. Both Block & Leviton and Holzer & Holzer, LLC are investig...